Call it Bernie Sanders vs. Ariad Pharmaceuticals, Act Two. The Vermont senator and erstwhile presidential candidate, who has helped make prescription drug pricing a high-profile issue, sent the company a letter on Thursday asking for a plethora of data that might explain a string of “staggering” and “outrageous” price hikes for an expensive cancer treatment. The…